Palomino Laboratories (PALX) Total Liabilities (2022 - 2025)
Palomino Laboratories (PALX) posted Total Liabilities of $336458.0 for Q4 2025, down 66.32% sequentially from $999013.0 in Q3 2025, and up 115.08% YoY from $156431.0 in Q4 2024.
Palomino Laboratories (PALX) Total Liabilities (2022 - 2025) Analysis & Trends
Palomino Laboratories has reported Total Liabilities for 4 years, with the latest figure at $336458.0 in Q4 2025.
- Quarterly Total Liabilities rose 115.08% year-over-year to $336458.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $336458.0 (up 115.08% YoY) and the FY2025 annual result came in at $336458.0, up 115.08% from the prior year.
- Total Liabilities declined to $336458.0 in Q4 2025 per PALX's latest filing, from $999013.0 in the prior quarter.
- Over five years, Total Liabilities peaked at $999013.0 in Q3 2025 and troughed at $27804.0 in Q4 2022.
- A 4-year average of $271921.0 and a median of $194658.0 in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities surged 40.14% in 2024, then soared 350.51% in 2025.
- Over 4 years, Total Liabilities stood at $27804.0 in 2022, then jumped by 301.46% to $111621.0 in 2023, then surged by 40.14% to $156431.0 in 2024, then soared by 115.08% to $336458.0 in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $336458.0, $999013.0, and $364431.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,458.00 |
| Sep 30, 2025 | 999,013.00 |
| Jun 30, 2025 | 364,431.00 |
| Mar 31, 2025 | 336,989.00 |
| Dec 31, 2024 | 156,431.00 |
| Sep 30, 2024 | 221,754.00 |
| Jun 30, 2024 | 194,658.00 |
| Mar 31, 2024 | 162,925.00 |
| Dec 31, 2023 | 111,621.00 |
| Sep 30, 2023 | 79,047.00 |
| Dec 31, 2022 | 27,804.00 |